Bristol Myers Squibb Co. and Pfizer Inc. have introduced a new direct-to-patient purchasing option for Eliquis through Eliquis 360 Support. Eliquis is a blood-thinning medication that reduces blood clotting and prevents strokes. Pfizer plans to launch a direct-to-consumer medicines platform called "Pfizer for All" in May 2024 following the success of its COVID-19 vaccine rollout. In August 2024, Pfizer introduced the PfizerForAll digital platform to provide medical information, mail-order pharmacy services, and telehealth services to US patients in collaboration with UpScriptHealth, Alto Pharmacy, and Instacart. Eligible US patients with an Eliquis prescription can start purchasing the medicine at a discounted rate through Eliquis 360 Support from September 8th onwards.